Sanofi Pasteur VaxDesign Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Grant

  • Financing Rounds
  • 4

Sanofi Pasteur VaxDesign General Information

Description

Developer of in vitro models of the human immune system intended to prevent infectious diseases. The company specializes in predictive in vitro immunological models and assays that can predict the immune response of an individual or selected group to a drug candidate or vaccine candidate providing clinically relevant information much earlier in the development process, thereby enabling researchers to forecast vaccine responses before clinical trials.

Contact Information

Website
www.vaxdesign.com
Formerly Known As
VaxDesign
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 2501 Discovery Drive
  • Suite 300
  • Orlando, FL 32826
  • United States
Primary Industry
Biotechnology
Acquirer
Sanofi Pasteur Biologics
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • 2501 Discovery Drive
  • Suite 300
  • Orlando, FL 32826
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sanofi Pasteur VaxDesign Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sanofi Pasteur VaxDesign‘s full profile, request access.

Request a free trial

Sanofi Pasteur VaxDesign Patents

  • 164

    Total Documents Applications and Grants

  • Total Patents Families

  • 140

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Sanofi Pasteur VaxDesign Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2017325009-B2 In vitro neonatal biomimetic (nmimic) model and methods of using same Active 08-Sep-2016
AU-2017325009-A1 In vitro neonatal biomimetic (nmimic) model and methods of using same Active 08-Sep-2016
US-20190187127-A1 In vitro neonatal biomimetic (nmimic) model and methods of using same Active 08-Sep-2016
US-11156601-B2 In vitro neonatal biomimetic (nmimic) model and methods of using same Active 08-Sep-2016
EP-3510143-B1 In vitro neonatal biomimetic (nmimic) model and methods of using same Active 08-Sep-2016 G01N33/505
To view Sanofi Pasteur VaxDesign’s complete patent history, request access »

Sanofi Pasteur VaxDesign FAQs

  • When was Sanofi Pasteur VaxDesign founded?

    Sanofi Pasteur VaxDesign was founded in 2003.

  • Where is Sanofi Pasteur VaxDesign headquartered?

    Sanofi Pasteur VaxDesign is headquartered in Orlando, FL.

  • What industry is Sanofi Pasteur VaxDesign in?

    Sanofi Pasteur VaxDesign’s primary industry is Biotechnology.

  • Is Sanofi Pasteur VaxDesign a private or public company?

    Sanofi Pasteur VaxDesign is a Private company.

  • What is Sanofi Pasteur VaxDesign’s current revenue?

    The current revenue for Sanofi Pasteur VaxDesign is .

  • When was Sanofi Pasteur VaxDesign acquired?

    Sanofi Pasteur VaxDesign was acquired on 31-Dec-2020.

  • Who acquired Sanofi Pasteur VaxDesign?

    Sanofi Pasteur VaxDesign was acquired by Sanofi Pasteur Biologics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »